10/9/2024

Mannitol Injection

Products Affected - Description

- Osmitrol injection, Baxter, 100 mg/mL, 500 mL premixed bag, 24 count, NDC 00338-0353-03
- Osmitrol injection, Baxter, 200 mg/mL, 500 mL premixed bag, 24 count, NDC 00338-0357-03
- Mannitol injection, BBraun, 200 mg/mL, 500 mL premixed bag, 1 count, NDC 00264-7578-10
- Mannitol injection, ICU Medical, 200 mg/mL, 250 mL premixed bag, 24 count, NDC 00990-7715-02
- Mannitol injection, ICU Medical, 200 mg/mL, 500 mL premixed bag, 12 count, NDC 00990-7715-03

Reason for the Shortage

- Baxter has sustained damage to their North Cove plant that supplies large volume fluids.

Available Products

- Mannitol injection, Fresenius Kabi, 250 mg/mL, 50 mL vial, 25 count, NDC 63323-0024-25
- Mannitol injection, Pfizer, 250 mg/mL, 50 mL vial, 25 count, NDC 00409-4031-01

Estimated Resupply Dates

- All premixed presentations are on allocation.

Alternative Agents & Management

- See ASHP Suggestions for Management and Conservation during Fluid Shortages at https://www.ashp.org/drug-shortages/shortage-resources/publications/fluid-shortages-suggestions-for-management-and-conservation

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.